Aventiv Research Inc
Aventiv Research Inc
Columbus, Ohio, United States1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS | DNA Virus Infections, Infections, milker's nodule, smallpox, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-14 | NCT04957485 |